Neumora Therapeutics Inc. (NMRA) Stock Is Looking Attractive
Deutsche Bank raised the price target for the Neumora Therapeutics Inc. (NASDAQ:NMRA) stock to “a Hold”. The rating was released on December 12, 2023, according to finviz. The research report from Stifel has initiated the stock to Buy, with a price target set at $26. The stock was initiated by RBC Capital Mkts, who disclosed […]
Does Neumora Therapeutics Inc. (NMRA) Stock have plenty of room for growth?
Deutsche Bank raised the price target for the Neumora Therapeutics Inc. (NASDAQ:NMRA) stock to “a Hold”. The rating was released on December 12, 2023, according to finviz. The research report from Stifel has initiated the stock to Buy, with a price target set at $26. The stock was initiated by RBC Capital Mkts, who disclosed […]
Neumora Therapeutics Inc. (NMRA) Stock is more thoughtful than you think
Deutsche Bank raised the price target for the Neumora Therapeutics Inc. (NASDAQ:NMRA) stock to “a Hold”. The rating was released on December 12, 2023, according to finviz. The research report from Stifel has initiated the stock to Buy, with a price target set at $26. The stock was initiated by RBC Capital Mkts, who disclosed […]
Why Neumora Therapeutics Inc. (NASDAQ:NMRA) Stock Slipped -27.23% in Last Month?
Deutsche Bank raised the price target for the Neumora Therapeutics Inc. (NASDAQ:NMRA) stock to “a Hold”. The rating was released on December 12, 2023, according to finviz. The research report from Stifel has initiated the stock to Buy, with a price target set at $26. The stock was initiated by RBC Capital Mkts, who disclosed […]
A Tale from the Dusty Corner: Neumora Therapeutics Inc. (NMRA) Stock
Deutsche Bank raised the price target for the Neumora Therapeutics Inc. (NASDAQ:NMRA) stock to “a Hold”. The rating was released on December 12, 2023, according to finviz. The research report from Stifel has initiated the stock to Buy, with a price target set at $26. The stock was initiated by RBC Capital Mkts, who disclosed […]